| 000 | 01336 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514181218.0 | ||
| 264 | 0 | _c20041014 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a0145-5680 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayor, A M | |
| 245 | 0 | 0 |
_aRecurrent pneumonia mortality risk in a HIV/AIDS Puerto Rican cohort. _h[electronic resource] |
| 260 |
_bCellular and molecular biology (Noisy-le-Grand, France) _cDec 2003 |
||
| 300 |
_a1199-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 |
_aPneumococcal Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aPneumonia _xetiology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aPuerto Rico _xepidemiology |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 700 | 1 | _aGomez, M A | |
| 700 | 1 | _aRios, E | |
| 700 | 1 | _aHunter, R F | |
| 773 | 0 |
_tCellular and molecular biology (Noisy-le-Grand, France) _gvol. 49 _gno. 8 _gp. 1199-204 |
|
| 999 |
_c14705226 _d14705226 |
||